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Introduction
Squamous cell carcinoma (SCC) of the head and neck 
may be classified by anatomic sites such as the maxilla, 
oropharynx, larynx and hypopharynx. Although the 
recommendations for treatment had been developed by 
tumor site, tumor-node-metastasis (TNM) staging and 
histological diagnosis, they do not always predict clinical 
results precisely (1). Despite the slow decline in its incidence 
(about 4% since 1980), head and neck SCC remains a 
clinical challenge. In the Brazilian population, the floor of 
the mouth represents the second most prevalent anatomic 
site in oral SCC after the tongue (2).
Tumor invasion is a dynamic, complex process with 
several stages, which involves the displacement of 
malignant cells from their point of origin, traversing the 
extracellular matrix and basal membrane and invasion of 
blood and lymphatic vessels. Proteolysis of the components 
of the basement membrane and extracellular matrix are 
essential steps in tissue invasion, therefore specific proteases 
are required for the degradation of collagen, laminin and 
fibronectin. For this reason, matrix metalloproteinases 
(MMPs), which are zinc-dependent proteases, have been 
studied extensively (3).
The aim of this study was to evaluate the immunoexpression of MMP-2, MMP-9 and 
CD31/microvascular density in squamous cell carcinomas of the floor of the mouth and to 
correlate the results with demographic, survival, clinical (TNM staging) and histopathological 
variables (tumor grade, perineural invasion, embolization and bone invasion). Data from 
medical records and diagnoses of 41 patients were reviewed. Histological sections were 
subjected to immunostaining using primary antibodies for human MMP-2, MMP-9 and 
CD31 and streptavidin-biotin-immunoperoxidase system. Histomorphometric analyses 
quantified positivity for MMPs (20 fields per slide, 100 points grade, ×200) and for CD31 
(microvessels <50 μm in the area of the highest vascularization, 5 fields per slide, 100 
points grade, ×400). Statistical design was composed by non-parametric Mann-Whitney 
U test (investigating the association between numerical variables and immunostainings), 
chi-square frequency test (in contingency tables), Fisher’s exact test (when at least one 
expected frequency was less than 5 in 2x2 tables), Kaplan-Meier method (estimated 
probabilities of overall survival) and Iogrank test (comparison of survival curves), all 
with a significance level of 5%. There was a statistically significant correlation between 
immunostaining for MMP-2 and lymph node metastasis. Factors associated negatively with 
survival were N stage, histopathological grade, perineural invasion and immunostaining 
for MMP-9. There was no significant association between immunoexpression of CD31 
and the other variables. The intensity of immunostaining for MMP-2 can be indicative 
of metastasis in lymph nodes and for MMP-9 of a lower probability of survival. 
A general concept is that increased angiogenesis leads 
to a greater ability to invade and produce metastases. The 
precise role of microvascular density (MVD)/CD31+ cells in 
the prognosis of SCC is yet to be fully established. Some 
authors believe that a greater MVD leads to a poorer 
prognosis (4) whereas others believe the opposite (5). In 
addition, the majority of studies in this field do not make 
a distinction between different head and neck tumor sites 
that can display heterogeneous vascular networks (4,6).
In this way, besides showing their importance in 
the knowledge of tumor pathogenesis, MMPs and 
angiogenesis could contribute as potential biomarkers in 
diagnosis and prognosis of oral cancer. For this reason, 
this study aimed to evaluate the MMP-2, MMP-9 and 
CD31/MVD immunoexpression in SCC of the floor of the 
mouth, correlating microscopic parameters with tumor 
aggressiveness or patient survival.
Material and Methods
Patients
This study was approved by the institutional Ethics 
Committee (registration protocol #632/04 on January 28th 
2004 at A.C. Camargo Cancer Hospital and #177/2004 on 
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March 8th 2005 at Bauru Dental School, University of 
São Paulo). 
The eligibility requirements for the 41 individuals 
participating in this study carried out at the A.C. Camargo 
Cancer Hospital - Antônio Prudente Foundation (São Paulo, 
SP, Brazil) were as follows: i) medical records registered with 
histological diagnosis of primitive malignant neoplasm in 
floor of the mouth between 1970 and 1993; ii) patient 
adherence to the treatment with curative purpose 
(excluding isolated antineoplastic chemotherapy) until 
its termination; and iii) availability of formalin-fixed 
and paraffin-embedded human carcinoma samples for 
immunohistochemical analysis. 
Demographic, survival, clinical (TNM staging) and 
histopathological variables were also reviewed.
Demographic and Survival Variables
Medical records provided the data for demographic 
analysis (gender, race, habits, age of diagnosis), as well as 
for the evaluation of overall survival of the patients (lifetime 
after diagnosis/treatment and duration of follow-up). The 
last evaluation of the medical records was performed on 
November 2007. 
TNM Staging
Neoplasm staging described in medical records followed 
the TNM system according to International Union Against 
Cancer (U.I.C.C.), where: T (Tx - primary tumor could not 
be identified, T0 - no evidence of primary tumor, Tis - 
carcinoma in situ; T1 - tumor extension <2 cm; T2 - tumor 
extension >2 cm and <4 cm; T3 - tumor extension >4 cm 
and T4 - tumor invading adjacent structures), N (Nx - lymph 
node could not be identified; N0 - no evidence of lymph 
node involvement; N1 - single ipsilateral lymph node 
involvement <3 cm; N2a - single ipsilateral lymph node 
involvement >3 cm and <6 cm; N2b - multiple ipsilateral 
lymph nodes involvement <6 cm; N2c - bilateral lymph 
nodes involvement <6 cm; N3 - lymph nodes involvement 
>6 cm) and M (Mx - distant metastasis could not be 
identified; M0 - no evidence of distant metastasis; M1 - 
presence of distant metastasis). 
The clustering of cases in clinical stages obeyed the 
following organization: Stage 0 (Tis N0 M0), Stage I (T1 N0 
M0), Stage II (T2 N0 M0), Stage III (T3 N0 M0 or T1-T2-T3 
N1 M0), Stage IV (T4 N2-N3 M1).
Histopathological Variables
From the corresponding paraffin blocks, 5-μm-thick 
sections were prepared, stained with hematoxylin and eosin 
and examined by a pathologist experienced in this field. 
Detailed description of the samples included evaluation of 
perineural invasion, presence of vascular tumor emboli and 
histological tumor grading (well differentiated, moderately 
differentiated and poorly differentiated carcinomas). 
Immunohistochemical Procedures
Histological sections were mounted on silanized 
slides with poly-D-lysine, heated in oven at 56oC for 1 
h, deparaffinized using 3 baths of xylol and rehydrated 
with 2 baths of ethanol 100% and 1 bath of ethanol 
95% (5 min in each step). Next, they were submitted to 
2 baths of phosphate buffered saline (PBS, pH=7.2-7.4) 
for 5 min. Endogenous peroxidases and serum proteins 
were inactivated for 15 min with 3% hydrogen peroxide 
and serum-free protein block, respectively, and washed in 
PBS. The recovery of the epitopes of protein antigens was 
accomplished by heating the sections at 95ºC in a 10 mM 
sodium citrate buffer for 30 min and a new wash in PBS. 
Primary antibodies against human MMP-2 (AF902; R&D 
Systems, Minneapolis, MN, USA), MMP-9 (AF911; R&D 
Systems) and CD31 (SC-1506; Santa Cruz Biotechnology, 
Santa Cruz, CA, USA) were diluted 1:250 in PBS containing 
1% bovine serum albumin (BSA) and dropped upon the 
slides which remained in wet chamber at room temperature 
for 1 h. Then the sections were washed in PBS, aspirated 
and exposed to the biotinylated secondary antibody 
rabbit anti-goat IgG-HRP (E066; Dako Cytomation Inc., 
Mississauga, ON, Canada) at room temperature for 15 min. 
All sections were washed three times in PBS and incubated 
in streptavidin-peroxidase for 30 min. The negative control 
was obtained by substituting the primary antibody with 
PBS/BSA in each batch. The slides were washed tree times 
with PBS, and after aspiration of the excess, they were 
exposed to a chromogenic substrate 3,3’-diaminobenzidine 
(DAB; Dako Cytomation Inc.) for 5 min. The slides were 
washed with distilled water, counter-stained with Harris 
Hematoxylin for 1 min and the excess removed with rinse 
in distilled water. Additionally, 3 shorter baths of ethanol 
100%, 3 baths of xylol and bonding of coverslips with 
syntethic resin Entellan (Merck, Darmstadt, Germany) 
completed the procedure.
Histological and Histomorphometric Analyses of 
Immunostainings
The immunohistochemical preparations were evaluated 
by a person unaware of the clinicopathological status 
of the patients. Photomicrographs of non superimposed 
contiguous fields were obtained with a digital camera 
(Cybershot DSC-W300; Sony, Manaus, AM, Brazil) connected 
to an optical microscope (FWL-1000; Feldman Wild Leitz, 
Manaus, AM, Brazil) and analyzed using Image Pro-Plus 
6.0 (MediaCybernetics, San Diego, CA, USA), calibrated in 
micrometer/pixel and with a virtual 100-point grade for 
counting of immunostained dots.
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MMP-2 and MMP-9 expressions were evaluated in 
photomicrographs of SCC with ×200 magnification in 20 
fields per slide. The number of points that coincided with 
positive marking for MMPs was counted in each area. The 
representative average percentage of the immunostained 
fields in each lesion was obtained. Values above 10% were 
considered positive in the classification of MMP status. 
The CD31/MVD expression was determined in 
photomicrographs of SCC with total ×400 magnification in 
5 fields from area of highest vascular density in the tumor 
per slide. Vessels up to 50 μm in diameter were considered 
for counting. Isolated cells or groups of vascular cells 
without a visible lumen were not included. 
Statistical Design
The numeric variables and the frequency distribution 
of the category variables were evaluated using descriptive 
statistics of measurements with central tendencies and 
variability. The non-parametric Mann-Whitney U test was 
used to evaluate the association between the numeric 
variables and the markers, and the chi-square test of 
frequencies was applied to the contingency tables. Fisher’s 
exact test was applied when at least one value was less than 
5 in 2x2 tables. The probabilities of overall survival were 
estimated by the Kaplan-Meier method and the comparison 
of survival curves was carried out using the Iogrank test. 
The follow-up period was defined as the interval between 
the date of surgery and the date of either death or the last 
status information. A significance level of 5% was applied 
to all statistical tests.
Results
In the obtained sample, there was a predominance 
of men and poor survival rate. Thirty-six subjects were 
males and 5 were females and their ages ranged from 39 
to 95 years (mean age: 54.8 years). At the last check of the 
records, only 4 subjects were alive, 24 had died of cancer, 
8 had died from other causes, and 5 subjects were lost to 
follow-up. The shortest follow-up was 12 days and the 
longest was 8,171 days, with a mean follow-up period of 
1,897 days. More than one half (51.2%) of the tumors were 
well differentiated, 36.6% were moderately differentiated 
and 12.2% were poorly differentiated. Approximately 80% 
of the subjects were in an advanced clinical stage (III and 
IV) and 56.1% had lymph node metastases. The number 
of vessels found per slide ranged from 20 to 46, with an 
average of 21.3 ± 7.8 used as an analysis parameter of MVD. 
All three biomarkers were positive for SCC of floor of 
the mouth. MMP-2 had stronger staining for fibroblasts in 
the tumor stroma and weaker for epithelial tumor cells and 
inflammatory cells. MMP-9 expression was concentrated 
in the macrophage-rich inflammatory infiltrate but had 
also weak staining for fibroblast-like cells and tumor cells 
in the basal layer of epithelium. CD31 staining vascular 
endothelium aided identification of blood microvessels 
and obtaining the value of MVD (Fig. 1). 
The distribution of demographic and clinical variables 
according to MMP-2 (Table 1) and MMP-9 expressions (Table 
2) showed labeling with MMP-2 correlated to N positive 
stage, indicating lymph node metastasis at the time of initial 
diagnosis while the positivity for MMP-9 is not related to 
the demographic data (p>0.05). The analysis of demographic 
and clinical variables in function of MVD showed a lower 
degree of embolization (Table 3). The presence of only one 
case of bone invasion this category inappropriate for the 
assessment of correlation with molecular variables and the 
prognosis of patients. 
Table 1. Distribution of demographic variables, TNM staging and 
histopathological variables for MMP-2 immunostaining
Variables and categories
Negative
Frequency 
(%) 
Positive
Frequency 
(%) 
p value
Gender
 Male
 Female
17 (42.2)
2 (40)
19 (52.8)
3 (60)
0.999*
Age of diagnosis
 N
 Minimum-maximum
 Median
 Average ± SD
19
42-95
56
57.8 ± 11.9
22
39-69
53.5
52.2 ± 8.3
0.084**
T stage
 T1+T2
 T3+T4
9 (45)
10 (47.6)
11 (55)
11 (52.4)
0.867
N stage
 N0
 N positive
12 (66.7)
7 (30.4)
6 (33.3)
16 (69.6)
0.030*
Tumor grade
 Poorly + Moderately (II+II)
 Well differentiated (I)
10 (50)
9 (42.9)
10 (50)
12 (57.1)
0.678
Perineural invasion
 Negative
 Positive
12 (42.9)
7 (53.8)
16 (57.1)
6 (46.2)
0.511
Embolization
 Negative
 Positive
13 (43.3)
6 (54.5)
17 (56.7)
5 (45.5)
0.524
Bone invasion
 Negative
 Positive
18 (45)
1 (100)
22 (55)
0 (0)
NA
SD: standard deviation; NA: not applicable; p: Chi square frequency 
test; *p: Fisher’s exact test; **p: Mann-Whitney U test.
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Analysis of distribution in negative and positive cases 
among molecular variables showed no correlation of 
MMPs expression with MVD. However, there was negative 
correlation between MMP-9 and MMP-2 (p=0.018, Mann-
Whitney U test, data not shown).
The relationship between the analyzed variables and 
patient survival is shown in Figure 2. The 5-year survival rate 
was 36.6% and the 10-year rate was 30.6%. The Iogrank 
test revealed that positive N stage, a poorly differentiated 
histological grade, the perineural invasion and MMP-9 
expression were associated with poorer survival rates. 
Discussion
Tumorigenesis and tumor progression are based on at 
least seven fundamental changes in cell physiology: 1) 
production of signs of autocrine growth; 2) insensitivity 
to signs of growth inhibition; 3) escape from apoptosis; 
4) loss of senescence; 5) maintenance of angiogenesis; 
6) tissue invasion; 7) metastases (7). The ability to invade 
tissues and establish colonies in remote sites certainly are 
characteristics that define malignant neoplasms. Since 
metastases are the main cause of death in cancer patients, 
a better understanding of the processes of tumor invasion 
and metastasis is indispensable and it can lead to the 
identification of new forms of treatment (3).
There is no consensus about the cell types most directly 
involved in the production of MMP-2 and MMP-9 in the 
tumor progression. Some authors state that tumor cells 
produce higher levels of proteolytic enzymes than normal 
cells (8) or indirectly stimulate the adjacent stromal cells 
Table 3. Distribution of demographic variables, TNM staging and 
histopathological variables for CD31/MVD immunostaining 
Variables
 and categories
≤ 21
Frequency 
(%) 
> 21
Frequency 
(%) 
p-value
Gender
 Male
 Female
18 (50)
2 (40)
18 (50)
3 (60)
0.999*
Age of diagnosis
 N
 Minimum-maximum
 Median
 Average ± SD
20
42-67
57
56 ± 6.9
21
39-95
53
56.7 ± 12.9
0.140**
T stage
 T1+T2
 T3+T4
12 (60)
8 (38.1)
8 (40)
13 (61.9)
0.161
N stage
 N0
 N positive
7 (38.9)
13 (56.5)
11 (61.9)
10 (43.5)
0.262
Tumor grade
 Poorly + Moderately (II+II)
 Well differentiated (I)
12 (60)
8 (38.1)
8 (40)
13 (61.9)
0.161
Perineural invasion
 Negative
 Positive
14 (50)
6 (46.1)
14 (50)
7 (53.9)
0.819
Embolization
 Negative
 Positive
10 (33.3)
10 (91.9)
20 (66.7)
1 (9.1)
0.001*
Bone invasion
 Negative
 Positive
19 (47.5)
1 (100)
21 (52.5)
0 (0)
DNA
SD: standard deviation; NA: not applicable; p: Chi square frequency 
test; *p: Fisher’s exact test; **p: Mann-Whitney U test.
Table 2. Distribution of demographic variables, TNM staging and 
histopathological variables for MMP-9 immunostaining
Variables 
and categories
Negative
Frequency 
(%) 
Positive
Frequency 
(%) 
p 
value
Gender
 Male
 Female
25 (69.4)
2 (40)
11 (30.4)
3 (60)
0.317*
Age of diagnosis
 N
 Minimum-maximum
 Median
 Average ± SD
27
40-95
54
55.48 ± 11.5
14
39-67
55
53.5 ± 8.1
0.783**
T stage
 T1+T2
 T3+T4
15 (75)
12 (57.1)
5 (25)
9 (42.9)
0.228
N stage
 N0
 N positive
14 (77.8)
13 (56.5)
4 (22.2)
10 (43.5)
0.154
Tumor grade
 Poorly + Moderately (II+II)
 Well differentiated (I)
12 (60)
15 (71.4)
8 (40)
6 (28.6)
0.440
Perineural invasion
 Negative
 Positive
20 (71.4)
7 (53.8)
8 (28.6)
6 (46.2)
0.307*
Embolization
 Negative
 Positive
19 (63.3)
8 (72.7)
11 (36.7)
3 (27.7)
0.709*
Bone invasion
 Negative
 Positive
27 (67.5)
0 (0)
13 (32.5)
1 (100)
NA
SD: standard deviation; NA: not applicable; p: Chi square frequency 
test; *p: Fisher’s exact test; **p: Mann-Whitney U test.
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to secrete them, opening a tissue space for tumor invasion 
(3,9). The production of MMP by the stroma can also be 
interpreted as a feature of epithelial tumors that have lost 
their ability to produce MMP due to the dedifferentiation 
process (3). The most accepted hypothesis is the main 
production of MMP-2 and MMP-9 by stromal tumor cells 
including fibroblasts, inflammatory cells and endothelial 
cells, playing an active role in carcinogenesis and tumor 
invasion (9) similar to the outcomes of this study, with 
marked expression of MMP-2 and MMP-9 in the stroma. 
It is important to highlight the participation of the 
inflammatory component of a neoplasm, which includes 
a diverse cell population (neutrophils, dendritic cells, 
macrophages, eosinophils, mast cells and lymphocytes) able 
to producing cytokines, mediators, proteases and MMPs, 
keeping close correlation with modulation of extracellular 
matrix degradation and tumor invasion (2,10). 
MMP-2 was more strongly immunostained in fibroblast-
like cells of tumor stroma. Fibroblasts are important in 
cancer progression due to release of MMP-2 on a larger scale 
and facilitation for the tumor invasion and metastasis (11). 
MMP-2 in this work was a rare condition in inflammatory 
cells. This suggests that the invasion afforded by MMP-2 is 
not influenced by local inflammation close to the tumor. The 
significant relationship between MMP-2 and lymph node 
metastasis corroborates other findings (3). A less expressive 
staining for MMP-2 in the basal membrane could suggest 
that tumor cells stimulate the MMPs expression in their 
environment to promote catabolism of extracellular matrix 
(type IV collagen) by the phagocytic host cells, paving the 
way for the tumor expansion (11).
Predominant immunostaining for MMP-9 in 
inflammatory cells does indicate that an expressive 
inflammatory reaction around the tumor increases the 
MMP-9 concentration and the risk of tumor invasion 
resulting from the action of gelatinase. A greater dissolution 
of extracellular matrix creates space for the tumor mass, 
facilitates intratumoral angiogenesis, decreases cellular 
adhesion and sustains the metastasis (12). However, one 
might consider that chronic inflammation as the body’s 
normal reaction can promote the release of compounds 
that prevent tumor progression (10). MMPs also influence 
the angiogenesis promoting release of pro-angiogenic 
molecules (VEGF and angiopoetin) and anti-angiogenic 
molecules (angiostatin) (11). In particular, MMP-9 action 
also generates tumstatin and endostatin, cleavage 
fragments of the alpha-3 chain of type IV collagen and 
alpha-1 chain of type XVIII collagen with anti-angiogenic 
properties (12). For this dual influence in the mechanism 
of angiogenesis, it was considered plausible the lack of 
correlation between MMPs and MVD studied in this work, 
corroborating other similar results (13). On the other hand, 
the relationship found between MMP-9 and poor prognosis 
refutes other findings (14) and deserves further study. 
Tumor vascularization is an essential factor for tumor 
progression. Without angiogenesis, the tumor mass cannot 
exceed a critical size and is restricted to a tissue diffusion 
distance of about 0.2 mm (15). In the present study, no 
relationship was found between MVD and clinical or 
histological parameters such as T or N stage, histological 
grade, perineural invasion or patient survival. Other 
authors have equally failed to find such associations in 
SCC of head and neck, which may indicate that the tumor 
Figure 1. Immunohistochemical evaluation of SCC of the floor of the 
mouth. A: Positive staining for MMP-2 in the connective stroma (*). 
B: MMP-9 expression in an intense, macrophage-rich inflammatory 
infiltrate in the stroma (white arrow). C: CD31 expression in endothelium 
of a blood microvessel (black arrow). Amplification: 20× (A, B); 40× (C).
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physiopathology is more complex than the mere presence 
or absence of vessels, and the interaction of various factors 
that influence tumor progression makes it difficult to 
objectively evaluate the effect of each individual factor 
(4,16). This behavior could be explained in the use of hot 
spot method, highly variable for counting of MVD in 
low-vascularization regions between SCC islets leading to 
misinterpretation (4), or due to unspecific immunostaining 
of newly formed blood vessels and pre-existing ones, 
disabling its prognostic importance (16). Furthermore, 
the fact that different sites have different degrees of 
vascularization may hinder the evaluation of recurrence and 
metastasis rates (4,6,17). The present study comprises only 
SCCs of the floor of the mouth and yet no such correlations 
were found, as opposite to other studies with correlation 
between MVD and tumor aggressiveness (13), tumor size 
(18) or tumor grade (19). There was a negative correlation 
between MVD and embolization, which may be attributed 
to a deficiency of the newly formed vessels in performing 
their usual functions, such as gas exchange and supplying 
nutrients to the neoplasm (15). Furthermore, the presence 
of endothelial cells may favor tumor invasion through 
cytokine production, thus creating a chemically attractive 
environment for tumor cells (20). On the other hand, if one 
considers that new vessels formed in an uncontrolled way 
in a tumor mass are not always functional, their capabilities 
of chemoattraction and of supplying nutrients to the tumor 
may be impaired, thus hindering the penetration of tumor 
cells and explaining the lack of correlation between the 
MVD and the other evaluated parameters.
The literature attempts to establish an association 
between some histological variables and SCC prognosis. 
Factors such as lymph node metastases and histological 
grade have a clear correlation with cancer prognosis 
(2,21,22). The present study found a significant correlation 
between survival, lymph node metastases, more aggressive 
histological grades (II and III) and perineural invasion. The 
latter has been reported as a negative prognostic factor 
in the development of SCC (2,5). Tumor propagation 
could occur through the perineural connective tissue that 
envelops the peripheral nerves because of its low resistance 
(23). Other authors reported that malignant tumors of the 
floor of mouth with perineural space invasion are more 
prone to metastasize to cervical lymph nodes, suggesting 
higher aggressiveness and more recurrences (24). The 
overexpression of neural growth factor in salivary gland 
carcinomas may be a reason for their affinity for nerves, 
perhaps being a marker for perineural invasion in such 
lesions in humans (25). Although the present study has 
shown a significant correlation between perineural invasion 
and poor survival, data that could aid in the selection of a 
more effective therapy, more studies are needed in order 
to determine the molecular mechanisms involved in this 
process.
Figure 2. Kaplan-Meier survival estimates according to: (A) N stage, (B) histological grade, (C) perineural invasion and (D) MMP-9 status.
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Based on the results obtained in SCC of the floor of the 
mouth, it is possible to conclude that MMP-2 expression 
could be indicative of lymph node metastasis and MMP-9 
is associated with lower probability of survival. There was 
no significant association between immunoexpression of 
CD31/MVD and the other variables.
Resumo
O objetivo deste estudo foi avaliar a imunoexpressão de MMP-2, MMP-
9 e CD31/densidade microvascular em carcinomas espinocelulares de 
soalho bucal e correlacionar os resultados com variáveis demográficas, 
de sobrevida, clínicas (estadiamento TNM) e histopatológicas (grau 
de diferenciação tumoral, invasão perineural, embolização e invasão 
óssea). Dados de prontuários e de diagnósticos de 41 pacientes foram 
revisados. Cortes histológicos foram submetidos à imunomarcação usando 
anticorpos primários para MMP-2, MMP-9 e CD31 humanos e sistema 
streptoavidina-biotina-imunoperoxidase. Análise histomorfométrica 
quantificou a positividade para MMPs (20 campos, grade de 100 pontos 
por lâmina, ×200) e para CD31 (microvasos <50 μm na área de maior 
vascularização, 5 campos, grade de 100 pontos por lâmina, ×400). O 
planejamento estatístico foi composto pelo teste não paramétrico U 
de Mann-Whitney (verificação da associação entre variáveis numéricas 
e imunomarcações), teste de frequências do qui-quadrado (em tabelas 
de contingência), teste exato de Fisher (quando pelo menos uma 
frequência esperada foi menor do que 5 em tabelas 2x2), método de 
Kaplan-Meier (estimativa de probabilidades de sobrevida global) e teste 
de Iogrank (comparação das curvas de sobrevida), todos com nível de 
significância de 5%. Houve correlação estatisticamente significante 
entre imunomarcação para MMP-2 e metástase em linfonodo. Os fatores 
relacionados negativamente com a sobrevida foram estadiamento N, 
gradação histopatológica, invasão perineural e imunomarcação de MMP-
9. Não houve associação significativa entre imunoexpressão de CD31 e 
as demais variáveis. A intensidade de imunomarcação para MMP-2 pode 
ser indicativa de metástase em linfonodo e para MMP-9 de uma menor 
probabilidade de sobrevida. 
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